SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis	hepatocellular carcinoma	Recruiting	Phase 2	2026-03-04		NCT06823375

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chinese University of Hong Kong	480

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Department of Clinical Oncology, Prince of Wales Hospital	Hong Kong	Hong Kong	16
Department of Clinical Oncology, Tuen Mun Hospital	Hong Kong	Hong Kong	2

Clinical trials